These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 22087824)

  • 1. Determinants of increased cardiovascular disease in obesity and metabolic syndrome.
    Vazzana N; Santilli F; Sestili S; Cuccurullo C; Davi G
    Curr Med Chem; 2011; 18(34):5267-80. PubMed ID: 22087824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic syndrome, a cardiovascular disease risk factor: role of adipocytokines and impact of diet and physical activity.
    Robinson LE; Graham TE
    Can J Appl Physiol; 2004 Dec; 29(6):808-29. PubMed ID: 15630152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolically Healthy and Unhealthy Normal Weight and Obesity.
    Stefan N
    Endocrinol Metab (Seoul); 2020 Sep; 35(3):487-493. PubMed ID: 32814419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic syndrome and cardiovascular diseases: Going beyond traditional risk factors.
    Silveira Rossi JL; Barbalho SM; Reverete de Araujo R; Bechara MD; Sloan KP; Sloan LA
    Diabetes Metab Res Rev; 2022 Mar; 38(3):e3502. PubMed ID: 34614543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular consequences of metabolic syndrome.
    Tune JD; Goodwill AG; Sassoon DJ; Mather KJ
    Transl Res; 2017 May; 183():57-70. PubMed ID: 28130064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular and renal effects of weight reduction in obesity and the metabolic syndrome.
    Cohen JB; Cohen DL
    Curr Hypertens Rep; 2015 May; 17(5):34. PubMed ID: 25833456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of increasing body mass index on cardio-metabolic risk and biomarkers of oxidative stress and inflammation in nascent metabolic syndrome.
    Pahwa R; Adams-Huet B; Jialal I
    J Diabetes Complications; 2017 May; 31(5):810-813. PubMed ID: 28285929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathophysiology and therapeutics of cardiovascular disease in metabolic syndrome.
    Wang Y; Yu Q; Chen Y; Cao F
    Curr Pharm Des; 2013; 19(27):4799-805. PubMed ID: 23323622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The metabolic syndrome and inflammation: actual issues of pathogenesis].
    Sveklina TS; Talantseva MS; Barsukov AV
    Klin Lab Diagn; 2013 Mar; (3):7-10. PubMed ID: 23808015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Obesity and cardiovascular disease: revisiting an old relationship.
    Koliaki C; Liatis S; Kokkinos A
    Metabolism; 2019 Mar; 92():98-107. PubMed ID: 30399375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Obesity-related cardiovascular risk in children and the role of lifestyle changes.
    Balagopal P
    J Cardiometab Syndr; 2006; 1(4):269-74; quiz 275-6. PubMed ID: 17679806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxidative stress as pathogenesis of cardiovascular risk associated with metabolic syndrome.
    Otani H
    Antioxid Redox Signal; 2011 Oct; 15(7):1911-26. PubMed ID: 21126197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Operative risk factors in the metabolic syndrome: is it lipids and high blood pressure or are there direct vascular effects of insulin resistance and obesity?
    Ukkola O
    Curr Cardiol Rep; 2006 Nov; 8(6):427-32. PubMed ID: 17059794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic syndrome: a marker of patients at high cardiovascular risk.
    Lau DC; Yan H; Dhillon B
    Can J Cardiol; 2006 Feb; 22 Suppl B(Suppl B):85B-90B. PubMed ID: 16498518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Visceral fat and metabolic syndrome: more than a simple association].
    Ribeiro Filho FF; Mariosa LS; Ferreira SR; Zanella MT
    Arq Bras Endocrinol Metabol; 2006 Apr; 50(2):230-8. PubMed ID: 16767289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelet activation in obesity and metabolic syndrome.
    Santilli F; Vazzana N; Liani R; Guagnano MT; Davì G
    Obes Rev; 2012 Jan; 13(1):27-42. PubMed ID: 21917110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The cardiovascular continuum in Asia--a new paradigm for the metabolic syndrome.
    Cheung BM
    J Cardiovasc Pharmacol; 2005 Aug; 46(2):125-9. PubMed ID: 16044022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ultrasound-assessed visceral fat and associations with glucose homeostasis and cardiovascular risk in clinical practice.
    Bellan M; Menegatti M; Ferrari C; Carnevale Schianca GP; Pirisi M
    Nutr Metab Cardiovasc Dis; 2018 Jun; 28(6):610-617. PubMed ID: 29656956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of albuminuria and the metabolic syndrome.
    Rowley K; O'Dea K; Best JD
    Curr Diab Rep; 2003 Feb; 3(1):80-6. PubMed ID: 12643150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors related to cardiovascular diseases and the metabolic syndrome in multiple sclerosis - a systematic review.
    Wens I; Dalgas U; Stenager E; Eijnde BO
    Mult Scler; 2013 Oct; 19(12):1556-64. PubMed ID: 24048545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.